Healthcare · Diagnostics & Research
No live calls today · full consensus board · no graded calls yet
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Recent news
| 2026-10-23 | Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer · globe_newswire |
| 2026-10-22 | Veracyte: Strong Diagnostic Growth And Improving Margins · seeking_alpha |
| 2026-10-20 | 4 - VERACYTE, INC. (0001384101) (Issuer) · sec_edgar_current |
| 2026-10-18 | Veracyte secures Medicare coverage: 11 analysts rate Veracyte stock · ad-hoc-news.de |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。